EVALUATION OF THE ASSOCIATION OF TUMOR BIOMARKERS WITH CHILDHOOD CANCERS

Şule ÇALIŞKAN KAMIŞ , Metin ÇİL , Begül YAĞCI KÜPELİ
{"title":"EVALUATION OF THE ASSOCIATION OF TUMOR BIOMARKERS WITH CHILDHOOD CANCERS","authors":"Şule ÇALIŞKAN KAMIŞ ,&nbsp;Metin ÇİL ,&nbsp;Begül YAĞCI KÜPELİ","doi":"10.1016/j.htct.2024.04.043","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>We aimed to investigate the indications for Carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen 125 (CA-125), carbohydrate antigen 15-3 (CA15-3) and carcinoembryogenic antigen (CEA) tumor biomarkers, less commonly used in children, and their association with patients diagnosed with childhood cancers.</p></div><div><h3>Methodology</h3><p>The study aimed to include patients aged 0-18 who had CA 19-9, CA-125, CA 15-3 and CEA tumor biomarker assessments at Adana City Training and Research Hospital (ACTRH) between 01.11.2022 and 01.11.2023. CA 19-9, CA-125, CA 15-3 and CEA values were recorded from routinely collected serum/blood samples of the patients. The relationship between tumor biomarkers and patients diagnosed with childhood cancers was evaluated.</p></div><div><h3>Results</h3><p>The study included 211 patients. Out of 211 patients, 145 (68.7%) were female, and 66 (31.3%) were male. Malignancy was detected in 35 patients (16.6%). There was no statistically significant relationship observed between CA 15-3, CA 19-9, and CEA positivity and the detection of malignancy. The respective p-values were found to be (p=0.711, p= 0.533, p=0.573). A statistically significant relationship was observed between CA-125 positivity and the detection of malignancy (p=0.002).</p></div><div><h3>Conclusion</h3><p>Tumor markers alone are not sufficient for making a definitive diagnosis or determining treatment decisions. However further comprehensive studies are needed for detection of association conventional tumor markers and childhood cancers.</p></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531137924001251/pdfft?md5=78cb5f38388d222e37665dba01ff65ef&pid=1-s2.0-S2531137924001251-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137924001251","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

We aimed to investigate the indications for Carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen 125 (CA-125), carbohydrate antigen 15-3 (CA15-3) and carcinoembryogenic antigen (CEA) tumor biomarkers, less commonly used in children, and their association with patients diagnosed with childhood cancers.

Methodology

The study aimed to include patients aged 0-18 who had CA 19-9, CA-125, CA 15-3 and CEA tumor biomarker assessments at Adana City Training and Research Hospital (ACTRH) between 01.11.2022 and 01.11.2023. CA 19-9, CA-125, CA 15-3 and CEA values were recorded from routinely collected serum/blood samples of the patients. The relationship between tumor biomarkers and patients diagnosed with childhood cancers was evaluated.

Results

The study included 211 patients. Out of 211 patients, 145 (68.7%) were female, and 66 (31.3%) were male. Malignancy was detected in 35 patients (16.6%). There was no statistically significant relationship observed between CA 15-3, CA 19-9, and CEA positivity and the detection of malignancy. The respective p-values were found to be (p=0.711, p= 0.533, p=0.573). A statistically significant relationship was observed between CA-125 positivity and the detection of malignancy (p=0.002).

Conclusion

Tumor markers alone are not sufficient for making a definitive diagnosis or determining treatment decisions. However further comprehensive studies are needed for detection of association conventional tumor markers and childhood cancers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估肿瘤生物标志物与儿童癌症的关系
目的 我们旨在调查儿童较少使用的碳水化合物抗原 19-9 (CA19-9)、碳水化合物抗原 125 (CA-125)、碳水化合物抗原 15-3 (CA15-3) 和癌胚抗原 (CEA) 肿瘤生物标志物的适应症及其与确诊儿童癌症患者的关联。方法该研究旨在纳入2022年11月1日至2023年11月1日期间在阿达纳市培训与研究医院(ACTRH)接受CA 19-9、CA-125、CA 15-3和CEA肿瘤生物标志物评估的0-18岁患者。CA 19-9、CA-125、CA 15-3和CEA的值记录自患者常规采集的血清/血液样本。研究评估了肿瘤生物标志物与儿童癌症患者之间的关系。在211名患者中,145名(68.7%)为女性,66名(31.3%)为男性。35名患者(16.6%)发现了恶性肿瘤。CA 15-3、CA 19-9和CEA阳性与恶性肿瘤的检出率之间没有统计学意义上的显著关系。P值分别为(P=0.711、P= 0.533、P=0.573)。CA-125阳性与恶性肿瘤的检出之间有统计学意义(P=0.002)。然而,要检测常规肿瘤标志物与儿童癌症之间的关系,还需要进一步的综合研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.40
自引率
4.80%
发文量
1419
审稿时长
30 weeks
期刊最新文献
The challenge of timely diagnosis and management of acute leukemias and associated infections in Latin America The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy A SUCCESSFUL CASE OF PRIMARY PLASMA CELL LEUKEMIA TREATED WITH DARATUMUMAB-BASED THERAPY FOLLOWED BY AUTOLOGOUS BONE MARROW TRANSPLANTATION CARCINOMA EX PLEOMORPHIC ADENOMA: DIAGNOSTIC CHALLENGE AND TREATMENT PROTOCOL
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1